Will Weisman
Founder & Managing Partner @ KittyHawk
Los Angeles, United States
Will Weisman is a seed investor at KittyHawk in Los Angeles focused on Health Care and Artificial Intelligence. Will Weisman is the founder and Managing Partner of KittyHawk, an investment firm focused on leading edge seed to late stage pre-IPO companies.The firm is named after Kitty Hawk, North Carolina, where the Wright Brothers embarked on an extraordinary entrepreneurial journey, creating the world’s first airplane and launching a new era in humanmobility.KittyHawk supports extraordinary, mission driven entrepreneurs in their quest to build world changing organizations. The firm operates two primary strategies: KittyHawk Frontier focuses on seed stage investments at the frontiers of technology including AI, Quantum, Aerospace, Healthcare, Longevity, Climate, Web 3 and more.KittyHawk Secondaries are pre-IPO secondary funds that leverage a deep relationship with Nasdaq Private Markets to access investment opportunities in the world’s leading late-stage companies.Previously Will spent seven years as an Executive Director at Singularity University, a think tank and educational institution that was founded by Ray Kurzweil and Peter Diamandis that focuses on leveraging accelerating technologies to solve the world’s biggest problems. Will helped build Singularity into a global benefit corporation with over 170 chapters in 159 countries, and 300k community members. Will also served as Executive Director of Peter Diamandis’ Abundance360.Among Will's most unusual accomplishments is that he created and popularized the wrap, yes, the burrito like food item, at a 30-unit restaurant chain he founded and sold called World Wrapps.Will has an MBA from Stanford and a BA from the University of California at Santa Barbara. He sits on numerous boards and also regularly speaks on exponential technology trends, venture investing and entrepreneurship. Will is an avid kiteboarder, wing-foiler and ocean swimmer. He resides in Los Angeles.
- Total investments:
- 76
- Last investment:
- Lead investor:
- 37%
Last updated:
For AI agents: llms.txt
Industries Will Weisman invests in
Stages Will Weisman invests in
Countries Will Weisman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 9 (12%)
- Artificial Intelligence 8 (11%)
- Software 6 (8%)
- Information Technology 5 (7%)
- FinTech 4 (5%)
Stage
- Seed 22 (29%)
- Series A 10 (13%)
- Pre-Seed 4 (5%)
- Funding Round 3 (4%)
- Series B 2 (3%)
Country
- United States 23 (30%)
- Chile 1 (1%)
- Brazil 1 (1%)
- Canada 1 (1%)
- France 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AI-driven infrastructure intelligence | Feb 24, 2026 | ||
| Solubag is a packaging products manufacturing company. | Series A / Dec 30, 2025 | ||
| Pryon is an artificial intelligence company focused on enterprise knowledge management. Its natural language processing platform transforms unstructured data into experiences that increase productivity with unmatched accuracy and speed. Pryon’s automated machine learning engines deliver rapid time to value by enriching existing content. Thisno-code approach prevents operational disruption and allows organizations to quickly maximize the business value trapped within their information assets. Pryon was founded by Igor Jablokov, whose previous company defined the state of the art for AI assistants and was acquired by Amazon to form the basis for Alexa. | Convertible Note / Dec 11, 2025 | ||
| At Anthropogenic Inc, we’re laying the groundwork for a new generation of financial products, where both the Investment Rate of Return + Impact Rate of Return or as we like to say, IRR² are the norm. Join us and help ensure that superior profits and planetary health co-exist for maximum ROI. | Pre-Seed / Jun 05, 2025 | ||
| Lykos Therapeutics' goal is to revolutionize the way mental health is addressed. By creating innovative medicines and therapeutic techniques to treat mental health disorders, we hope to upend the status quo. With over thirty years of expertise investigating therapies aided by psychedelics, we continue to be committed to adhering to rigorousscience so that we can create and market innovative treatment alternatives. | $50M / Series B / May 30, 2025 | ||
| xNilio synthesizes all product data to guide engineers in defining their prototype's design intent. Engineers set cost and performance goals; xNilio automatically generates the manufacturing data and plans to meet them. xNilio seamlessly fits into existing workflows, instantly regenerating manufacturing data for new CAD features and customerrequests. Cut down your product development time by 10x with xNilio. | Pre-Seed / Feb 10, 2025 | ||
| The Robot is an AI-driven company developing a blockchain platform. | Pre-Seed / Feb 08, 2025 | ||
|
geCKo Materials
|
Next Industrial Velcro | Seed / Dec 31, 2024 | |
| Goa Therapeutics offers a pipeline of therapeutic candidates targeting serious diseases through drug discovery and development services. The company operates in stealth mode, focusing on preclinical programs and translational research. It provides expertise in characterizing novel therapeutic modalities and managing early-stage developmentprocesses. It collaborates with academic and industry partners to advance molecules toward clinical readiness. Its scientific team applies techniques to optimize compound properties and assess safety and efficacy in relevant models. | Seed / Dec 31, 2024 | ||
| Qvin is the first and only healthcare service to use menstrual blood as a non-invasive blood test. We exist to give women an easy, insightful way to monitor existing health issues, proactively screen for others, and go into doctor visits more informed and confident of their own health. | Convertible Note / Apr 19, 2024 | ||
| See all 76 investments → | |||
Co-Investors
About KittyHawk
KittyHawk, an investment firm focused on leading edge seed to late stage pre-IPO companies. The firm is named after Kitty Hawk, North Carolina, where the Wright Brothers embarked on an extraordinary entrepreneurial journey, creating the world’s first airplane and launching a new era in human mobility.KittyHawk supports extraordinary, mission drivenentrepreneurs in their quest to build world changing organizations. The firm operates two primary strategies: - KittyHawk Frontier focuses on seed stage investments at the frontiers of technology including AI, Quantum, Aerospace, Healthcare, Longevity, Climate, Web 3 and more. - KittyHawk Secondaries are pre-IPO secondary funds that leverage a deep relationship with Nasdaq Private Markets to access investment opportunities in the world’s leading late-stage companies. The firm was founded in 2015 and is run by former Singularity University Executive Director, Will Weisman.
KittyHawk Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Paul Burgon
Partner
|
|||
|
Will Weisman
Founder & Managing Partner
|
|||
Alexandra Peterson Cart
Partner
|
|||
Carol Grunberg
Venture Partner
|
|||
|
John Pearce
COO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Will Weisman invest in?
Will Weisman invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 76 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Will Weisman?
Public channels for Will Weisman include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Will Weisman last invest?
The most recent investment recorded for Will Weisman closed in Feb 2026. Shizune tracks 76 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
